← board
HMDCF
distress 1/10 · well-funded / low risk$2.160%today-41% from 52w high
hutch-med.com1,796 employeesFounded 2000Hong Kong, Hong KongDrug Manufacturers - Specialty & Generic
Revenue
$549M
Liquidity
$1367M
Runway
21.1 yrs
Shares 1y
0%
Price & events
-28.5% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+0.0%
1W
+0.0%
1M
-23.4%
3M
-28.5%
6M
-32.6%
1Y
-43.4%
2Y
-57.7%
5Y
-57.7%
All
Overview
- Market Cap
- $1.88B
- Enterprise Value
- $1.88B
- Volume
- 0
- 52 Week Range
- $2.16 – $3.66
- Total Shares
- 872.33M
- Float Shares
- 513.62M
- % Held by Insiders
- 38.80%
- % Held by Institutions
- 19.38%
- Beta
- 0.43
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-07-30Confirmed 100%earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 872,327,620 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.